ABHD5 and prostate carcinoma: These findings suggest that while both ABHD5 and PNPLA2 are involved in lipid mobilization, only ABHD5 is required to suppress c-MYC protein expression, indicating a lipolysis-independent mechanism by which ABHD5 controls oncogenic MYC signaling in prostate cancer cells.